• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人工智能对难治性糖尿病性黄斑水肿行玻璃体切除术联合或不联合晶状体切开术的手术效果分析

AI-based analysis of surgical outcomes in vitrectomy with and without cystotomy for refractory cystoid diabetic macular edema.

作者信息

Mitamura Mizuho, Saito Michiyuki, Nishiyama-Hirooka Kiriko, Dong Zhenyu, Ando Ryo, Kase Satoru, Ishida Susumu

机构信息

Department of Ophthalmology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan.

出版信息

Sci Rep. 2025 Apr 26;15(1):14629. doi: 10.1038/s41598-025-93847-z.

DOI:10.1038/s41598-025-93847-z
PMID:40287472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12033233/
Abstract

The aim of this study was to compare surgical outcomes in vitrectomy with and without cystotomy for refractory cystoid diabetic macular edema (DME). This study enrolled 35 eyes of 29 patients who underwent vitrectomy for refractory DME. The eyes were divided into 2 groups, those undergoing vitrectomy with cystotomy (cystotomy group) (n = 8) and vitrectomy with internal limiting membrane (ILM) peeling only (ILM peeling group) (n = 27). The endpoints were central retinal thickness (CRT), best-corrected visual acuity (BCVA), macular fluid (MF) area. The MF area was determined and measured using a semantic segmentation model "Hokkaido University MF segmentation model" and subdivided into inner MF (IMF) area bounded by the inner nuclear layer (INL), and outer MF (OMF) area between the outer border of INL and ellipsoid zone. The cystotomy group showed a significant reduction in CRT at 1 month postoperatively compared to the ILM peeling group (P < 0.05). The cystotomy group preserved BCVA at 6 months postoperatively compared to preoperatively. There was a significant difference between the cystotomy and the ILM peeling groups in the reduction of the OMF area at 1 month postoperatively (P < 0.01). Cystotomy for refractory DME was more effective in reducing the OMF area.

摘要

本研究的目的是比较有或没有行晶状体切开术的玻璃体切除术治疗难治性囊样糖尿病性黄斑水肿(DME)的手术效果。本研究纳入了29例因难治性DME接受玻璃体切除术的患者的35只眼。这些眼被分为两组,一组接受玻璃体切除术联合晶状体切开术(晶状体切开术组)(n = 8),另一组仅接受玻璃体切除术联合内界膜(ILM)剥除术(ILM剥除术组)(n = 27)。观察指标为中心视网膜厚度(CRT)、最佳矫正视力(BCVA)、黄斑区积液(MF)面积。使用语义分割模型“北海道大学MF分割模型”确定并测量MF面积,并将其细分为以内核层(INL)为界的内MF(IMF)面积和INL外边界与椭圆体带之间的外MF(OMF)面积。与ILM剥除术组相比,晶状体切开术组术后1个月CRT显著降低(P < 0.05)。与术前相比,晶状体切开术组术后6个月BCVA得以保留。晶状体切开术组与ILM剥除术组在术后1个月OMF面积减少方面存在显著差异(P < 0.01)。难治性DME的晶状体切开术在减少OMF面积方面更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/20fc39690e79/41598_2025_93847_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/8af6a0961663/41598_2025_93847_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/ad5d4de9e222/41598_2025_93847_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/10da3a6d54bd/41598_2025_93847_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/9dcd8d31308c/41598_2025_93847_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/86e7b7bbb033/41598_2025_93847_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/7b61c892cf1b/41598_2025_93847_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/20fc39690e79/41598_2025_93847_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/8af6a0961663/41598_2025_93847_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/ad5d4de9e222/41598_2025_93847_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/10da3a6d54bd/41598_2025_93847_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/9dcd8d31308c/41598_2025_93847_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/86e7b7bbb033/41598_2025_93847_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/7b61c892cf1b/41598_2025_93847_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f85/12033233/20fc39690e79/41598_2025_93847_Fig6_HTML.jpg

相似文献

1
AI-based analysis of surgical outcomes in vitrectomy with and without cystotomy for refractory cystoid diabetic macular edema.基于人工智能对难治性糖尿病性黄斑水肿行玻璃体切除术联合或不联合晶状体切开术的手术效果分析
Sci Rep. 2025 Apr 26;15(1):14629. doi: 10.1038/s41598-025-93847-z.
2
Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling.吲哚菁绿辅助内界膜剥除玻璃体切割术后弥漫性糖尿病性黄斑水肿的视神经萎缩。吲哚菁绿辅助内界膜剥除的不良影响。
Graefes Arch Clin Exp Ophthalmol. 2004 Dec;242(12):995-9. doi: 10.1007/s00417-004-0864-4. Epub 2004 Jul 17.
3
Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.伴有或不伴有内界膜剥除的玻璃体切除术治疗糖尿病性黄斑水肿
Ophthalmologica. 2005 Jul-Aug;219(4):206-13. doi: 10.1159/000085729.
4
[Is removal of internal limiting membrane always necessary during surgery for refractory diffuse diabetic macular edema without evident epimacular proliferation?].[在治疗无明显黄斑前增殖的难治性弥漫性糖尿病性黄斑水肿的手术中,是否总是需要剥除内界膜?]
Klin Monbl Augenheilkd. 2006 Aug;223(8):681-6. doi: 10.1055/s-2006-926606.
5
Six-month postoperative outcomes of intraoperative OCT-guided surgical cystotomy for refractory cystoid macular edema in diabetic eyes.糖尿病性眼病中难治性黄斑囊样水肿患者术中光学相干断层扫描(OCT)引导下手术性膀胱切开术的术后6个月结局
Clin Ophthalmol. 2017 Nov 23;11:2099-2105. doi: 10.2147/OPTH.S150385. eCollection 2017.
6
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.玻璃体后皮质切除术联合内界膜剥除术治疗糖尿病性黄斑水肿
Retina. 2008 Mar;28(3):410-9. doi: 10.1097/IAE.0b013e31816102f2.
7
Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.改良格栅激光光凝术与玻璃体切割联合内界膜剥除术治疗糖尿病性黄斑水肿的比较
Am J Ophthalmol. 2005 May;139(5):795-801. doi: 10.1016/j.ajo.2004.12.017.
8
Foveal Microstructure Analysis in Eyes with Diabetic Macular Edema Treated with Vitrectomy.糖尿病性黄斑水肿患者玻璃体切除术后的中心凹微观结构分析。
Adv Ther. 2017 Sep;34(9):2139-2149. doi: 10.1007/s12325-017-0598-4. Epub 2017 Aug 14.
9
Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.玻璃体切除术与染料增强内界膜剥除联合格栅激光治疗弥漫性糖尿病性黄斑水肿的比较评估
Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):360-8. doi: 10.1007/s00417-006-0456-6. Epub 2006 Nov 9.
10
ILM peeling in nontractional diabetic macular edema: review and metanalysis.非牵引性糖尿病性黄斑水肿的内界膜剥除术:综述与荟萃分析
Int Ophthalmol. 2018 Dec;38(6):2709-2714. doi: 10.1007/s10792-017-0761-6. Epub 2017 Oct 31.

本文引用的文献

1
Clinicopathological findings in refractory diabetic macular edema: A case report.难治性糖尿病性黄斑水肿的临床病理发现:一例报告。
Biomed Rep. 2023 Nov 29;20(1):13. doi: 10.3892/br.2023.1701. eCollection 2024 Jan.
2
LONG-TERM EFFECT OF CYSTOTOMY WITH OR WITHOUT THE FIBRINOGEN CLOT REMOVAL FOR REFRACTORY CYSTOID MACULAR EDEMA SECONDARY TO DIABETIC RETINOPATHY.纤维蛋白凝块去除与否的囊切开术对糖尿病性视网膜病变继发难治性囊样黄斑水肿的长期疗效。
Retina. 2021 Apr 1;41(4):844-851. doi: 10.1097/IAE.0000000000002921.
3
Validation of automated artificial intelligence segmentation of optical coherence tomography images.
光学相干断层扫描图像的自动化人工智能分割验证。
PLoS One. 2019 Aug 16;14(8):e0220063. doi: 10.1371/journal.pone.0220063. eCollection 2019.
4
EFFECTIVENESS OF EN BLOC REMOVAL OF FIBRINOGEN-RICH COMPONENT OF CYSTOID LESION FOR THE TREATMENT OF CYSTOID MACULAR EDEMA.整块切除含血纤维蛋白的囊样病变成分治疗囊样黄斑水肿的疗效。
Retina. 2020 Jan;40(1):154-159. doi: 10.1097/IAE.0000000000002359.
5
Six-month postoperative outcomes of intraoperative OCT-guided surgical cystotomy for refractory cystoid macular edema in diabetic eyes.糖尿病性眼病中难治性黄斑囊样水肿患者术中光学相干断层扫描(OCT)引导下手术性膀胱切开术的术后6个月结局
Clin Ophthalmol. 2017 Nov 23;11:2099-2105. doi: 10.2147/OPTH.S150385. eCollection 2017.
6
PARS PLANA VITRECTOMY FOR DIABETIC MACULAR EDEMA: A Systematic Review, Meta-Analysis, and Synthesis of Safety Literature.用于治疗糖尿病性黄斑水肿的玻璃体切割术:一项安全性文献的系统评价、荟萃分析及综合研究
Retina. 2017 May;37(5):886-895. doi: 10.1097/IAE.0000000000001280.
7
Diabetic Retinopathy and Diabetic Macular Edema.糖尿病视网膜病变和糖尿病性黄斑水肿。
Dev Ophthalmol. 2016;55:137-46. doi: 10.1159/000438970. Epub 2015 Oct 26.
8
Diabetic Retinopathy: Vascular and Inflammatory Disease.糖尿病视网膜病变:血管性和炎症性疾病
J Diabetes Res. 2015;2015:582060. doi: 10.1155/2015/582060. Epub 2015 Jun 7.
9
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.阿柏西普、贝伐单抗或雷珠单抗治疗糖尿病性黄斑水肿。
N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18.
10
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.《da Vinci 研究:VEGF 陷阱眼内注射治疗糖尿病黄斑水肿的一年结果》。
Ophthalmology. 2012 Aug;119(8):1658-65. doi: 10.1016/j.ophtha.2012.02.010. Epub 2012 Apr 24.